Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts

Cancer Microenvironment

Volumn 2, Issue 1, 2009, Pages 9-21

  Sadlonova, Andrea ^a,d   Bowe, Damon B ^e   Novak, Zdenek ^b   Mukherjee, Shibani ^a,f   Duncan, Virginia E ^a   Page, Grier P ^c   Frost, Andra R ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Fibroblasts; Fibulin 1; Gene expression profiling; Stroma

Indexed keywords

DICKKOPF 1 PROTEIN; FIBULIN; NEU DIFFERENTIATION FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC IDENTIFICATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STROMA; TUMOR GENE;

EID: 73449119923     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-008-0017-0     Document Type: Article

References (47)

1. ES Radisky DC Radisky 2007 Stromal induction of breast cancer: inflammation and invasion Rev Endocr Metab Disord 8 279 287 10.1007/s11154-007- 9037-1 17447144 (Pubitemid 47524870)
2. TD Tlsty LM Coussens 2006 Tumor stroma and regulation of cancer development Annu Rev Pathol 1 119 150 10.1146/annurev.pathol.1.110304.100224 1:CAS:528:DC%2BD28XktVOitb0%3D 18039110
3. A Sadlonova Z Novak MR Johnson, et al. 2005 Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture Breast Cancer Res 7 R46 59 10.1186/bcr949 15642169
4. A Orimo PB Gupta DC Sgroi, et al. 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 335 348 10.1016/j.cell.2005.02.034 1:CAS:528:DC%2BD2MXktlSiu7w%3D 15882617 (Pubitemid 40692295)
5. MP Shekhar J Werdell SJ Santner RJ Pauley L Tait 2001 Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression Cancer Res 61 1320 1326 1:CAS:528:DC%2BD3MXhvVelsbY%3D 11245428
6. A Sadlonova S Mukherjee DB Bowe, et al. 2007 Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease Am J Pathol 170 1064 1076 10.2353/ajpath.2007.060031 1:CAS:528: DC%2BD2sXjs1Wlsbs%3D 17322389 (Pubitemid 47339373)
7. TT Tan LM Coussens 2007 Humoral immunity, inflammation and cancer Curr Opin Immunol 19 209 216 10.1016/j.coi.2007.01.001 1:CAS:528:DC%2BD2sXislehsr4%3D 17276050 (Pubitemid 46356960)
8. F Balkwill 2004 Cancer and the chemokine network Nat Rev Cancer 4 540 550 10.1038/nrc1388 1:CAS:528:DC%2BD2cXlt1Oktrs%3D 15229479
9. NM Hawsawi H Ghebeh SF Hendrayani, et al. 2008 Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes Cancer Res 68 2717 2725 10.1158/0008-5472.CAN-08- 0192 1:CAS:528:DC%2BD1cXks1Gitbo%3D 18413739 (Pubitemid 351556269)
10. H Koyama N Kobayashi M Harada, et al. 2008 Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment Am J Pathol 172 179 193 10.2353/ajpath.2008.070360 1:CAS:528:DC%2BD1cXhslOmurc%3D 18079437 (Pubitemid 351186379)
11. AK Sasser BL Mundy KM Smith, et al. 2007 Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments Cancer Lett 254 255 264 10.1016/j.canlet. 2007.03.012 1:CAS:528:DC%2BD2sXosFKjs7c%3D 17467167 (Pubitemid 47161104)
12. C Kuperwasser T Chavarria M Wu, et al. 2004 From the cover: reconstruction of functionally normal and malignant human breast tissues in mice Proc Natl Acad Sci U S A 101 4966 4971 10.1073/pnas.0401064101 1:CAS:528:DC%2BD2cXjsFCis70%3D 15051869 (Pubitemid 38469186)
13. C Blanquicett MR Johnson M Heslin RB Diasio 2002 Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies Anal Biochem 303 209 214 10.1006/abio.2001.5570 1:CAS:528:DC%2BD38XislSgur4%3D 11950223 (Pubitemid 34407587)
14. AR Frost D Sparks WE Grizzle 2000 Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry Appl Immunohistochem Mol Morphol 8 236 243 10.1097/00022744-200009000-00011 1:CAS:528:DC%2BD3cXmslWgtrw%3D 10981877 (Pubitemid 30677911)
15. LI Talley WE Grizzle JW Waterbor D Brown H Weiss AR Frost 2002 Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women Int J Cancer 98 118 127 10.1002/ijc.10171 1:CAS:528:DC%2BD38Xht1Wgtr8%3D 11857395 (Pubitemid 34113428)
16. DC Chhieng SO Tabbara EF Marley LI Talley AR Frost 2003 Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma Breast J 9 200 207 10.1046/j.1524-4741.2003.09311.x 1:CAS:528:DC%2BD3sXltVSgtb0%3D 12752628 (Pubitemid 36627165)
17. Grizzle WE, Myers RB, Manne U, Stockard CR, Harkins LE, Srivastava S (1998) Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia. In: Hanausek M, Walaszek Z (eds) John Walker's methods in molecular medicine-tumor marker protocols. Humana, Totowa, NJ, pp 161-179
18. SM Pupa WS Argraves S Forti, et al. 2004 Immunological and pathobiological roles of fibulin-1 in breast cancer Oncogene 23 2153 2160 10.1038/sj.onc.1207323 1:CAS:528:DC%2BD2cXitFCmsLg%3D 14691454 (Pubitemid 38482530)
19. P Trivedi JW Edwards J Wang, et al. 2005 HDBStat!: a platform-independent software suite for statistical analysis of high dimensional biology data BMC Bioinformatics 6 86 10.1186/1471-2105-6-86 15813968 (Pubitemid 41357929)
20. WO Twal A Czirok B Hegedus, et al. 2001 Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility J Cell Sci 114 4587 4598 1:CAS:528:DC%2BD38XnvFKktA%3D%3D 11792823
21. Y Hayashido A Lucas C Rougeot S Godyna WS Argraves H Rochefort 1998 Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin Int J Cancer 75 654 658 10.1002/(SICI)1097- 0215(19980209)75:4<654::AID-IJC26>3.0.CO;2-7 1:CAS:528:DyaK1cXhtV2ksb0%3D 9466671 (Pubitemid 28094116)
22. J Qing VM Maher H Tran WS Argraves RW Dunstan JJ McCormick 1997 Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines Oncogene 15 2159 2168 10.1038/sj.onc.1201385 1:CAS:528:DyaK2sXnsFajsro%3D 9393974
23. LM Greene WO Twal MJ Duffy, et al. 2003 Elevated expression and altered processing of fibulin-1 protein in human breast cancer Br J Cancer 88 871 878 10.1038/sj.bjc.6600802 1:CAS:528:DC%2BD3sXitFegsbg%3D 12644824 (Pubitemid 36520874)
24. A Bardin F Moll R Margueron, et al. 2005 Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells Endocrinology 146 760 768 10.1210/en.2004-1239 1:CAS:528: DC%2BD2MXotlWhuw%3D%3D 15528301 (Pubitemid 40129832)
25. F Moll D Katsaros G Lazennec, et al. 2002 Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells Oncogene 21 1097 1107 10.1038/sj.onc.1205171 1:CAS:528:DC%2BD38XhvFGqsLw%3D 11850827
26. F Moinfar YG Man L Arnould GL Bratthauer M Ratschek FA Tavassoli 2000 Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Res 60 2562 2566 1:CAS:528:DC%2BD3cXjtV2qtb0%3D 10811140
27. K Kurose K Gilley S Matsumoto PH Watson XP Zhou C Eng 2002 Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas Nat Genet 32 355 357 10.1038/ng1013 1:CAS:528: DC%2BD38Xot1Kls7o%3D 12379854 (Pubitemid 35266108)
28. K Kurose S Hoshaw-Woodard A Adeyinka S Lemeshow PH Watson C Eng 2001 Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions Hum Mol Genet 10 1907 1913 10.1093/hmg/10.18.1907 1:CAS:528:DC%2BD3MXntlSgsbw%3D 11555627
29. LA Kunz-Schughart R Knuechel 2002 Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol Histopathol 17 599 621 1:STN:280:DC%2BD383isVGhsQ%3D%3D 11962761
30. LA Kunz-Schughart R Knuechel 2002 Tumor-associated fibroblasts (part II): Functional impact on tumor tissue Histol Histopathol 17 623 637 1:STN:280:DC%2BD383isVGhtg%3D%3D 11962762
31. H Yu F Maurer RL Medcalf 2002 Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation Blood 99 2810 2818 10.1182/blood.V99.8.2810 1:CAS:528:DC%2BD38XivVyqu7g%3D 11929770 (Pubitemid 34525369)
32. M Ranson Z Tian NM Andronicos S Rizvi BJ Allen 2002 In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells Breast Cancer Res Treat 71 149 159 10.1023/A:1013850107791 1:CAS:528:DC%2BD38XitFehsLo%3D 11881911 (Pubitemid 34145372)
33. BJ Allen Z Tian SM Rizvi Y Li M Ranson 2003 Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2 Br J Cancer 88 944 950 10.1038/sj.bjc.6600838 1:CAS:528:DC%2BD3sXitFegtrk%3D 12644835 (Pubitemid 36520885)
34. AM Sieuwerts JW Martens LC Dorssers JG Klijn JA Foekens 2002 Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts Thromb Haemost 87 674 683 1:CAS:528:DC%2BD38Xjt1egtLY%3D 12008951
35. L Fredriksson H Li C Fieber X Li U Eriksson 2004 Tissue plasminogen activator is a potent activator of PDGF-CC EMBO J 23 3793 3802 10.1038/sj.emboj.7600397 1:CAS:528:DC%2BD2cXnvFCgt7g%3D 15372073 (Pubitemid 39389710)
36. AX Torres-Collado W Kisiel ML Iruela-Arispe JC Rodriguez-Manzaneque 2006 ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2 J Biol Chem 281 17827 17837 10.1074/jbc.M513465200 1:CAS:528:DC%2BD28XmtFyktrw%3D 16641089 (Pubitemid 44035581)
37. C Clavel M Polette M Doco I Binninger P Birembaut 1992 Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology Bull Cancer 79 261 270 1:STN:280:DyaK3s%2FgsFWjtA%3D%3D 1392165
38. N Nguyen A Kuliopulos RA Graham L Covic 2006 Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells Cancer Res 66 2658 2665 10.1158/0008-5472.CAN-05-2082 1:CAS:528:DC%2BD28XhvV2gsr4%3D 16510585
39. KW Adolph 1999 Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues Biochem Biophys Res Commun 258 792 796 10.1006/bbrc.1999.0710 1:CAS:528:DyaK1MXjtVSjt7s%3D 10329465 (Pubitemid 29290349)
40. S Esseghir A Kennedy P Seedhar, et al. 2007 Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins Clin Cancer Res 13 3164 3173 10.1158/1078-0432.CCR-07-0224 1:CAS:528:DC%2BD2sXmtVajtbY%3D 17545519 (Pubitemid 46944898)
41. G Turashvili J Bouchal G Burkadze Z Kolar 2006 Wnt signaling pathway in mammary gland development and carcinogenesis Pathobiology 73 213 223 10.1159/000098207 1:CAS:528:DC%2BD2sXjsVOqtbY%3D 17314492 (Pubitemid 46332829)
42. A Glinka W Wu H Delius AP Monaghan C Blumenstock C Niehrs 1998 Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction Nature 391 357 362 10.1038/34848 1:CAS:528:DyaK1cXot1Glug%3D%3D 9450748 (Pubitemid 28093502)
43. N Voorzanger-Rousselot D Goehrig F Journe, et al. 2007 Increased Dickkopf-1 expression in breast cancer bone metastases Br J Cancer 97 964 970 1:CAS:528:DC%2BD2sXhtFSnurfM 17876334
44. S Britsch 2007 The neuregulin-I/ErbB signaling system in development and disease Adv Anat Embryol Cell Biol 190 1 65 10.1007/978-3-540-37107-6-1 17432114
45. IM Krane P Leder 1996 NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice Oncogene 12 1781 1788 1:CAS:528:DyaK28XivVOht7k%3D 8622899
46. H Sasano T Suzuki Y Matsuzaki, et al. 1999 Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors alpha and beta in human breast carcinoma J Clin Endocrinol Metab 84 781 785 10.1210/jc.84.2.781 1:CAS:528:DyaK1MXhtVChsrs%3D 10022453 (Pubitemid 29075721)
47. C Palmieri S Saji H Sakaguchi, et al. 2004 The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts J Mol Endocrinol 33 35 50 10.1677/jme.0.0330035 1:CAS:528: DC%2BD2cXntFOltrg%3D 15291741 (Pubitemid 39206346)